Advertisement

The Latest

The FDA sent Johnson & Johnson a letter of warning because the company improperly marketed two products under the DePuy Orthopaedics unit, according to a redOrbit.com report.

After lowering profit forecasts for defibrillators and spinal products, Medtronic's share prices fell more than they had in the past 21 months, according to a Bloomberg Businessweek report.

Many orthopedic surgeons are looking beyond traditional methods of operation to incorporate new minimally invasive and biologic technology when treating their patients. For patients with knee damage, the most recent technology includes utilizing a combination of a natural bone and…

Kensey Nash, a medical device company focused on regenerative medicine, reported all-time revenue high for the fourth quarter of 2010 at $21.9 million, according to a company news release.

Advertisement